4.5 Review

A meta-analysis on the prognosis of exosomal miRNAs in all solid tumor patients

期刊

MEDICINE
卷 98, 期 16, 页码 -

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MD.0000000000015335

关键词

exosomal miRNAs; meta-analysis; prognosis; tumor

向作者/读者索取更多资源

Background: It has been reported that the encapsulated miRNAs from exosomes are potential biomarkers of tumors prognosis. Yet, the results are controversial, so it is obliged to do a meta-analysis to reach a definite conclusion. Materials and methods: Studies were searched for published in PubMed, Embase, and Web of Science databases until April 20, 2018. A meta-analysis was conducted to appraise the role of exosomal miRNAs in prognosis of cancer patients. Results: The different exosomal miRNAs expression was remarkably related to overall survival (OS) (hazard ratio [HR]=2.02, 95% confidence interval [CI]: 1.84-2.21) and disease-free survival (DFS) (HR=2.43, 95% CI: 1.86-3.17) of cancer patients. High exosomal miR-21 expression was associated with poor OS (HR=2.59; 95% CI: 1.71-3.90) and DFS (HR=1.84; 95% CI: 1.37-2.47). High exosomal miR-451a expression was associated with poor OS (HR=4.81; 95% CI: 2.33-9.93) and DFS (HR=2.64; 95% CI: 1.62-4.31). High exosomal miR-1290 expression was associated with poor OS (HR=1.73; 95% CI: 1.29-2.33). Low exosomal miR-638 expression was associated with poor OS (HR=2.25; 95% CI: 1.46-3.46). Conclusion: The expression levels of exosomal miRNAs, particularly miR-21, miR-451a, miR-1290, and miR-638 could strongly predict prognosis of solid tumor patients and might be a potential target for tumor treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据